Volume 18, Number 7—July 2012
Research
Retrospective Evaluation of Control Measures for Contacts of Patient with Marburg Hemorrhagic Fever
Table 2
Characteristic | High-risk contact, n = 45, no. (%) | Low-risk contact, n = 32, no. (%) | p value† |
---|---|---|---|
Sex | 0.004 | ||
F | 33 (73.0) | 13 (40.0) | |
M | 12 (37.0) | 19 (60.0) | |
Age, y | 0.127 | ||
<25 | 13 (29.0) | 2 (6.2) | |
26–35 | 9 (21.0) | 8 (25.2) | |
36–45 | 10 (22.0) | 10 (31.2) | |
46–55 | 10 (22.0) | 11 (34.3) | |
56–65 | 3 (6.0) | 1 (3.1) | |
Education | 0.002 | ||
Secondary | 8 (18.0) | 1 (3.0) | |
Vocational | 17 (37.0) | 4 (12.0) | |
Higher professional | 15 (34.0) | 22 (70.0) | |
University | 5 (11.0) | 5 (15.0) | |
Health status | 0.047 | ||
Excellent | 11 (24.0) | 15 (47.0) | |
Very good | 19 (42.0) | 6 (18.7) | |
Good | 15 (34.0) | 11 (34.3) | |
Reported conditions during monitoring period | |||
Temperature >38°C | 2 (4.4) | 2 (6.2) | 0.901 |
Headache | 17 (37.7) | 8 (25.0) | 0.064 |
Myalgia | 5 (11.1) | 1 (3.1) | 0.407 |
Malaise | 13 (29.0) | 10 (31.2) | 0.513 |
Nausea | 6 (13.3) | 2 (6.2) | 0.429 |
Abdominal pain | 6 (13.3) | 3 (9.3) | 0.482 |
Fatigue | 11 (24.0) | 6 (18.5) | 0.222 |
Vomiting | 1 (4.5) | 0 | 0.399 |
Diarrhea | 6 (13.3) | 1 (3.1) | 0.247 |
*High-risk contact, unprotected contact with the patient or her body fluids; low-risk contact, contact with the patient or her body fluids while following strict isolation measures. Boldface indicates statistical significance (p<0.05).
†By χ2 test.
Page created: June 08, 2012
Page updated: June 08, 2012
Page reviewed: June 08, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.